A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

ClinicalTrials.gov ID: NCT07662135

Public ClinicalTrials.gov record NCT07662135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)

Study identification

NCT ID: NCT07662135
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: AstraZeneca; Industry
Enrollment: 900 participants

Conditions and interventions

Conditions

Interventions

Elecoglipron Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 5, 2026
Primary completion: Jul 12, 2028
Completion: Jul 12, 2028
Last update posted: Jul 14, 2026

2026 – 2028

United States locations

U.S. sites: 30
U.S. states: 18
U.S. cities: 30

Facility	City	State	ZIP	Site status
Research Site	Peoria	Arizona	85382	Not yet recruiting
Research Site	Surprise	Arizona	85374	Not yet recruiting
Research Site	Concord	California	94520	Not yet recruiting
Research Site	Sacramento	California	95821	Not yet recruiting
Research Site	Victorville	California	92392	Not yet recruiting
Research Site	Fleming Island	Florida	32003	Not yet recruiting
Research Site	Lauderdale Lakes	Florida	33313	Not yet recruiting
Research Site	Leesburg	Florida	34748	Not yet recruiting
Research Site	Miami Lakes	Florida	33016	Not yet recruiting
Research Site	Ocoee	Florida	34761	Not yet recruiting
Research Site	Orlando	Florida	32804	Not yet recruiting
Research Site	Braintree	Massachusetts	02184	Not yet recruiting
Research Site	New Bedford	Massachusetts	02740	Not yet recruiting
Research Site	Saint Joseph	Michigan	49085	Suspended
Research Site	Saint Paul	Minnesota	55117	Not yet recruiting
Research Site	Kansas City	Missouri	64111	Not yet recruiting
Research Site	Omaha	Nebraska	68144	Not yet recruiting
Research Site	Las Vegas	Nevada	89119	Not yet recruiting
Research Site	Albuquerque	New Mexico	87102	Not yet recruiting
Research Site	The Bronx	New York	10451	Not yet recruiting
Research Site	Kinston	North Carolina	28504	Not yet recruiting
Research Site	Raleigh	North Carolina	27609	Not yet recruiting
Research Site	Winston-Salem	North Carolina	27103	Not yet recruiting
Research Site	Cincinnati	Ohio	45219	Not yet recruiting
Research Site	East Providence	Rhode Island	02914	Not yet recruiting
Research Site	Gaffney	South Carolina	29340	Not yet recruiting
Research Site	Greenville	South Carolina	29605	Not yet recruiting
Research Site	San Antonio	Texas	78257	Not yet recruiting
Research Site	Ogden	Utah	84405	Not yet recruiting
Research Site	Arlington	Virginia	22205	Suspended

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 139 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07662135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 14, 2026 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07662135 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →